Peracchi Mattia, Maddalena Giuliana, Lecchi Beatrice, Massi Federico, Toffolatti Silvia Laura
University of Milan, Department of Agricultural and Environmental Sciences - DiSAA, Milan, Italy.
Pest Manag Sci. 2025 Sep;81(9):5360-5367. doi: 10.1002/ps.8890. Epub 2025 May 12.
Zoxamide, a β-tubulin inhibitor, is widely used in vineyards to control downy mildew caused by the high-risk pathogen Plasmopara viticola. This study aimed to investigate the selection of zoxamide resistance and its characterization, providing practical insights for resistance management, through a twofold approach: a quantitative assessment of selection pressure effects on oospore populations and the molecular characterization of resistance-associated mutations in P. viticola strains.
A total of 126 populations sampled from 57 vineyards mainly located in North-eastern Italy, were analyzed over a 6-year period (2017-2022). Based on toxicological parameters, 90% of the samples were fully sensitive to zoxamide (EC < 0.2 mg/L; EC and MIC<10 mg/L). Resistant individuals, able to germinate at 100 mg/L zoxamide, were detected in low frequency (<12%) within 13 samples. Only two samples showed a high frequency of resistant individuals (24-33%). Resistance was primarily found in vineyards treated more than four times per season with zoxamide. Partial sequencing of β-tubulin gene revealed different polymorphisms at codon 239 associated with resistant isolates: the known C239S/G mutations, with the SG genotype being predominant, and a potential novel C239T mutation, not previously reported.
This study highlighted a low risk of resistance under moderate fungicide application frequencies, indicating the importance of limiting fungicide applications to preserve sensitivity. The genetic diversity of resistance mechanisms, reflected in the various mutations in the β-tubulin gene, underscores the need for a deeper investigation into the fitness of the different genotypes to evaluate resistance spread in P. viticola populations. © 2025 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
唑菌酰胺是一种β-微管蛋白抑制剂,广泛用于葡萄园防治由高风险病原体葡萄霜霉病菌引起的霜霉病。本研究旨在通过两种方法研究唑菌酰胺抗性的选择及其特征,为抗性管理提供实际见解:定量评估选择压力对卵孢子群体的影响以及葡萄霜霉病菌株中抗性相关突变的分子特征。
在6年期间(2017 - 2022年),对主要位于意大利东北部的57个葡萄园采集的126个样本群体进行了分析。根据毒理学参数,90%的样本对唑菌酰胺完全敏感(EC<0.2mg/L;EC和MIC<10mg/L)。在13个样本中检测到能够在100mg/L唑菌酰胺浓度下发芽的抗性个体,频率较低(<12%)。只有两个样本显示抗性个体的频率较高(24 - 33%)。抗性主要出现在每个季节用唑菌酰胺处理超过四次的葡萄园中。β-微管蛋白基因的部分测序揭示了与抗性分离株相关的第239位密码子处的不同多态性:已知的C239S/G突变,其中SG基因型占主导,以及一个潜在的新的C239T突变,此前未见报道。
本研究强调了在适度使用杀菌剂频率下抗性风险较低,表明限制杀菌剂使用以保持敏感性的重要性。β-微管蛋白基因中的各种突变反映出抗性机制的遗传多样性,凸显了深入研究不同基因型适应性以评估葡萄霜霉病菌群体中抗性传播的必要性。© 2025作者。由John Wiley & Sons Ltd代表化学工业协会出版的《害虫管理科学》。